Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,518.40
(
0.81%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
105.31
(
-0.43%
)
Bitcoin
81,216.20
(
0.90%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: md1225 post# 235678

Sunday, 09/20/2015 10:57:08 AM

Sunday, September 20, 2015 10:57:08 AM

Post# of 347009

You don't leave a 160 billion dollar company with benefits to set you the rest of your life to go work for Mickey mouses 200 million dollar company unless you have a guarantee.



I agree and if anyone honestly thinks that one leaves Gilead for Peregrine Pharmaceuticals just on a hunch and no belief that Peregrine is heading to bigger places soon .. would be not thinking straight.

Interesting days ahead

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote